Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-04-26 | Judith J. Robertson has served as a director since April 2019. |
| 2020-04-27 | Judith J. Robertson (3) 60 Director ... (3) Member of the Nominating and Corporate Governance Committee ... Director Compensation for Fiscal 2019 Judith J. Robertson 31,575 Fees Earned or Paid in Cash ($) 30,170 Option Awards ($) — All Other Compensation ($) 61,745 Total ($) |
| 2021-04-23 | Judith J. Robertson has served as a director since April 2019. ... Ms. Robertson’s pharmaceutical industry experience relating to executive leadership experience with pharmaceutical companies and her expertise with respect to sales, marketing and commercialization of pharmaceutical products are among the qualifications she brings to the Board and her service as a Director of the Company. |
| 2022-04-25 | Judith J. Robertson has served on our Board of Directors since April 2019. ... At the end of the last fiscal year, the Nominating and Corporate Governance Committee was composed of Mohammad Azab, Simon X. Benito, Terrence F. Blaschke and Judith J. Robertson. ... At the end of the last fiscal year, the Audit Committee was composed of the following directors: Simon X. Benito, Peter S. Garcia, David R. Hoffmann, Gail J. Maderis and Judy J. Robertson. |
| 2022-10-07 | Includes 356,132 shares held by Judith J. Robertson. Also includes 180,000 shares issuable upon exercise of options exercisable within 60 days of October 3, 2022. |
| 2023-04-27 | Judith J. Robertson has served on our Board of Directors since April 2019. ... At the end of the last fiscal year, the Nominating and Corporate Governance Committee was composed of Mohammad Azab, Terrence F. Blaschke and Judith J. Robertson. Ms. Robertson has served as Chair of the Committee since June 2022. ... At the end of the last fiscal year, the Audit Committee was composed of the following directors: Peter S. Garcia, David R. Hoffmann, Gail J. Maderis and Judy J. Robertson. ... Director Compensation for Fiscal 2022: Judith J. Robertson Fees Earned or Paid in Cash ($) 56,792, Option Awards ($) 23,150, Total ($) 79,942. |
| 2024-08-12 | Judith J. Robertson has served on our Board of Directors since April 2019. Ms. Robertson has served as the Chief Commercial Officer of Opthea Limited since January 2022. Ms. Robertson’s pharmaceutical industry experience relating to executive leadership experience with pharmaceutical companies and her expertise with respect to sales, marketing and commercialization of pharmaceutical products are among the qualifications she brings to our Board of Directors. Director Compensation for Fiscal 2023 shows cash fees of $60,000 and option awards valued at $23,115, totaling $83,115. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22